A Placebo-Controlled Add-On Trial of the Ampakine, CX516, for Cognitive Deficits in Schizophrenia

Authors: Donald Goff, J. Steven Lamberti, Andrew C. Leon, Michael F. Green, Alexander L. Miller, Jayendra K. Patel, Theo C. Manschreck, Oliver Freudenreich, Steve A. Johnson - Neuropsychopharmacology 2007 cited by 181